{"transactions":[{"id":1698099,"issuer":{"id":5986,"kind":"organization","name":"Pyxis Oncology, Inc.","symbol":"PYXS"},"owners":[{"id":95753,"kind":"person","name":"Kobayashi Ken","position":1,"cik":"0002003383","reported_name":"Kobayashi Ken","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-29T16:33:36.000Z","date":"2023-12-29","kind":"grant","planned":false,"acquired":true,"shares":110878,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option will vest upon the achievement of certain clinical milestones related to data disclosure for PYX-201."}],"balance_after":110878,"derivative":{"exercise_price":1.8,"expiration_date":"2033-12-29","underlying":"Common Stock","underlying_shares":110878},"source":{"system":"sec-edgar","filing":"0001209191-23-060006","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2003383/000120919123060006/doc4.xml","form_type":"4"}},{"id":1698098,"issuer":{"id":5986,"kind":"organization","name":"Pyxis Oncology, Inc.","symbol":"PYXS"},"owners":[{"id":95753,"kind":"person","name":"Kobayashi Ken","position":1,"cik":"0002003383","reported_name":"Kobayashi Ken","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-29T16:33:36.000Z","date":"2023-12-29","kind":"grant","planned":false,"acquired":true,"shares":443514,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option will vest over four years, with 25% vesting on November 27, 2024 and the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued employment through the applicable vesting dates."}],"balance_after":443514,"derivative":{"exercise_price":1.8,"expiration_date":"2033-12-29","underlying":"Common Stock","underlying_shares":443514},"source":{"system":"sec-edgar","filing":"0001209191-23-060006","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2003383/000120919123060006/doc4.xml","form_type":"4"}}]}